CTNNB1 and adenoma: Sequencing studies showed that LS-associated MMR-deficient adenomas display a lower frequency of APC or CTNNB1 mutations (37%), compared to that observed in LS-associated MMR-proficient adenomas (72%) or in sporadic adenomas [149].